Both the incidence and degree of bleeding events after peripheral revascularization match what’s seen for coronary revascularization and for lower-extremity amputation, new findings from the EUCLID ...

Measured one way, success for peripheral vascular intervention (PVI) in the femoropopliteal arteries for patients with intermittent claudication has improved, as the need for repeat PVI appears to be ...

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral ...

Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...

Contego Medical announced late-breaking clinical results from the PERFORMANCE III carotid stent study. At 30 days, the 146 patients in the study had no strokes or myocardial infarctions, and there ...

The treatment of patients with peripheral arterial disease has evolved tremendously since the early 1960s, when Charles Dotter first successfully revascularized a superficial femoral artery occlusion ...

Treatment with rivaroxaban plus aspirin significantly reduced the risk of major adverse limb and cardiovascular events in the VOYAGER PAD study. A supplemental New Drug Application (sNDA) for ...

The FDA approved the LimFlow system designed to stave off amputation for people with chronic limb-threatening ischemia (CLTI) and no treatment alternatives, device maker LimFlow SA announced Tuesday.

Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...

Please provide your email address to receive an email when new articles are posted on . IVUS-guided angioplasty for peripheral artery disease improved procedural outcomes vs. an angiography-guided ...